Literature DB >> 8532588

Pituitary adenylate cyclase-activating peptide (PACAP), a VIP-like peptide, has prolonged airway smooth muscle relaxant activity.

H D Foda1, H H Sharaf, A Absood, S I Said.   

Abstract

Pituitary adenylate cyclase-activating peptide (PACAP), a widely distributed peptide belonging to the vasoactive intestinal peptide (VIP) family of peptides, stimulates the accumulation of cyclic adenosine monophosphate (cAMP) in many tissues, with greater potency and efficacy than VIP. We report that PACAP-38 was one-third as potent and 70% as efficacious as VIP in producing relaxation of isolated perifused guinea pig strips, although it was approximately twice as effective in stimulating cAMP accumulation. The PACAP-38-induced relaxation, however, was five to eight times as prolonged as that of VIP, and its cAMP stimulation was also more sustained. The prolonged action of PACAP-38 is probably due to its greater resistance to enzymatic degradation. The data suggest that airway relaxation is not solely dependent on the total content of cAMP in airways. PACAP-38 exhibits properties that may be useful in the management of airway constriction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8532588     DOI: 10.1016/0196-9781(95)00087-z

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  5 in total

Review 1.  Stress and asthma: novel insights on genetic, epigenetic, and immunologic mechanisms.

Authors:  Stacy L Rosenberg; Gregory E Miller; John M Brehm; Juan C Celedón
Journal:  J Allergy Clin Immunol       Date:  2014-08-13       Impact factor: 10.793

2.  Effect of vasoactive intestinal peptide (VIP)-related peptides on cholinergic neurogenic and direct mucus secretion in ferret trachea in vitro.

Authors:  Y C Liu; A M Khawaja; D F Rogers
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

3.  Bronchodilation by an inhaled VPAC(2) receptor agonist in patients with stable asthma.

Authors:  A Lindén; L Hansson; A Andersson; M Palmqvist; P Arvidsson; C-G Löfdahl; P Larsson; J Lötvall
Journal:  Thorax       Date:  2003-03       Impact factor: 9.139

4.  Stress and Bronchodilator Response in Children with Asthma.

Authors:  John M Brehm; Sima K Ramratnam; Sze Man Tse; Damien C Croteau-Chonka; Maria Pino-Yanes; Christian Rosas-Salazar; Augusto A Litonjua; Benjamin A Raby; Nadia Boutaoui; Yueh-Ying Han; Wei Chen; Erick Forno; Anna L Marsland; Nicole R Nugent; Celeste Eng; Angel Colón-Semidey; María Alvarez; Edna Acosta-Pérez; Melissa L Spear; Fernando D Martinez; Lydiana Avila; Scott T Weiss; Manuel Soto-Quiros; Carole Ober; Dan L Nicolae; Kathleen C Barnes; Robert F Lemanske; Robert C Strunk; Andrew Liu; Stephanie J London; Frank Gilliland; Patrick Sleiman; Michael March; Hakon Hakonarson; Qing Ling Duan; Jay K Kolls; Gregory K Fritz; Donglei Hu; Negar Fani; Jennifer S Stevens; Lynn M Almli; Esteban G Burchard; Jaemin Shin; Elizabeth L McQuaid; Kerry Ressler; Glorisa Canino; Juan C Celedón
Journal:  Am J Respir Crit Care Med       Date:  2015-07-01       Impact factor: 21.405

5.  Influence of PACAP on oxidative stress and tissue injury following small-bowel autotransplantation.

Authors:  Andrea Ferencz; Boglarka Racz; Andrea Tamas; Dora Reglodi; Andrea Lubics; Jozsef Nemeth; Klara Nedvig; Karoly Kalmar-Nagy; Ors Peter Horvath; Gyorgy Weber; Erzsebet Roth
Journal:  J Mol Neurosci       Date:  2008-07-24       Impact factor: 3.444

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.